this post was submitted on 08 Dec 2023
70 points (100.0% liked)

Futurology

1742 readers
327 users here now

founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] hallettj@beehaw.org 4 points 10 months ago

To sum up some of the details of the article, this only applies to drugs developed using government funding. The Bayh-Dole Act of 1980 gave private companies the right to hold parents on drugs developed with public funding, but also included a safeguard, "march-in rights", which gives the government rights to override those patents. The new order introduces a policy of exercising those rights in some cases.

It seems that if this is used the government would grant rights to a competitor to sell the drug at a lower price.